|
Name |
2-hydroxy-8-methoxy-6-methyl-9-oxo-xanthene-1-carboxylic Acid
|
Molecular Formula | C16H12O6 | |
IUPAC Name* |
2-hydroxy-8-methoxy-6-methyl-9-oxoxanthene-1-carboxylic acid
|
|
SMILES |
CC1=CC2=C(C(=C1)OC)C(=O)C3=C(O2)C=CC(=C3C(=O)O)O
|
|
InChI |
InChI=1S/C16H12O6/c1-7-5-10(21-2)13-11(6-7)22-9-4-3-8(17)12(16(19)20)14(9)15(13)18/h3-6,17H,1-2H3,(H,19,20)
|
|
InChIKey |
BQOVQGSBHRLTFG-UHFFFAOYSA-N
|
|
Synonyms |
CHEMBL592384; 2-hydroxy-6-methyl-8-methoxy-9-oxo-9h-xanthene-1-carboxylic acid; 2-hydroxy-8-methoxy-6-methyl-9-oxo-xanthene-1-carboxylic Acid; BDBM50339594; 2-hydroxy-8-methoxy-6-methyl-9-oxo-9H-xanthene-1-carboxylic acid
|
|
CAS | NA | |
PubChem CID | 11438030 | |
ChEMBL ID | CHEMBL592384 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 300.26 | ALogp: | 3.0 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 93.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 22 | QED Weighted: | 0.703 |
Caco-2 Permeability: | -4.885 | MDCK Permeability: | 0.00000709 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.778 |
Human Intestinal Absorption (HIA): | 0.041 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.658 |
Blood-Brain-Barrier Penetration (BBB): | 0.045 | Plasma Protein Binding (PPB): | 86.05% |
Volume Distribution (VD): | 0.726 | Fu: | 11.00% |
CYP1A2-inhibitor: | 0.343 | CYP1A2-substrate: | 0.931 |
CYP2C19-inhibitor: | 0.069 | CYP2C19-substrate: | 0.057 |
CYP2C9-inhibitor: | 0.512 | CYP2C9-substrate: | 0.265 |
CYP2D6-inhibitor: | 0.457 | CYP2D6-substrate: | 0.15 |
CYP3A4-inhibitor: | 0.072 | CYP3A4-substrate: | 0.057 |
Clearance (CL): | 1.308 | Half-life (T1/2): | 0.831 |
hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.112 |
Drug-inuced Liver Injury (DILI): | 0.988 | AMES Toxicity: | 0.221 |
Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.105 |
Skin Sensitization: | 0.522 | Carcinogencity: | 0.11 |
Eye Corrosion: | 0.018 | Eye Irritation: | 0.945 |
Respiratory Toxicity: | 0.497 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002135 | 0.783 | D06GCK | 0.372 | ||||
ENC001749 | 0.714 | D0G5UB | 0.348 | ||||
ENC002404 | 0.658 | D0K8KX | 0.333 | ||||
ENC004289 | 0.600 | D04AIT | 0.326 | ||||
ENC005347 | 0.597 | D07MGA | 0.315 | ||||
ENC002668 | 0.577 | D0QD1G | 0.309 | ||||
ENC002106 | 0.573 | D06NSS | 0.292 | ||||
ENC005168 | 0.541 | D0G7IY | 0.292 | ||||
ENC002462 | 0.538 | D08LFZ | 0.282 | ||||
ENC002523 | 0.533 | D0Y7PG | 0.281 |